Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Title Clinical Proof-of-Principle Trial in Adult Subjects with Newly
Transcript
Title Clinical Proof-of-Principle Trial in Adult Subjects with Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-Cell Function Acronym NN9828-4150 Principal/Lead Investigator Professor Colin Dayan Participating Sites University Hospital of Wales Study Summary The aim of this trial is to assess clinical proof-of-principle of NNC0114-0006 and liraglutide on preservation of beta-cell function in adult subjects with newly diagnosed type 1 diabetes mellitus. UKCTG Number 18571 Study Sponsor Novo Nordisk
